P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapy

American Journal of Respiratory and Critical Care Medicine

Volumn 187, Issue 1, 2013, Pages 28-33

  Denlinger, Loren C ^a   Manthei, David M ^a   Seibold, Max A ^b   Ahn, Kwangmi ^c   Bleecker, Eugene ^d   Boushey, Homer A ^e   Calhoun, William J ^f   Castro, Mario ^g   Chinchili, Vernon M ^c   Fahy, John V ^e   Hawkins, Greg A ^d   Icitovic, Nicolina ^c   Israel, Elliot ^h   Jarjour, Nizar N ^a   King, Tonya ^c   Kraft, Monica ⁱ   Lazarus, Stephen C ^e   Lehman, Erik ^c   Martin, Richard J ^b   Meyers, Deborah A ^d   Peters, Stephen P ^d   Sheerar, Dagna ^a   Shi, Lei ^a   Sutherland, E Rand ^b   Szefler, Stanley J ^b   Wechsler, Michael E ^h   Sorkness, Christine A ^a   Lemanske, Robert F ^a   more..

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^g WASHINGTON UNIVERSITY   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Asthma; Asthma Clinical Research Network; Corticosteroids; Exacerbation

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; PREDNISONE; PURINERGIC P2X7 RECEPTOR; P2RX7 PROTEIN, HUMAN; SALBUTAMOL;

ADULT; AFRICAN AMERICAN; ALLELE; ARTICLE; ASTHMA; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GENE FUNCTION; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; DISEASE COURSE; FORCED EXPIRATORY VOLUME; GENETICS; IMMUNOLOGY; NUCLEAR PORE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADRENAL CORTEX HORMONES; ADULT; AFRICAN AMERICANS; ALBUTEROL; ASTHMA; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; NUCLEAR PORE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDNISONE; RECEPTORS, PURINERGIC P2X7;

MLCS; MLOWN;

EID: 84872003277     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201204-0750OC     Document Type: Article

References (43)

1. Willart MA, Lambrecht BN. The danger within: endogenous danger signals, atopy and asthma. Clin Exp Allergy 2009;39:12-19.
2. Idzko M, Hammad H, van Nimwegen M, Kool M, Willart MA, Muskens F, Hoogsteden HC, Luttmann W, Ferrari D, Di Virgilio F, et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 2007;13:913-919. (Pubitemid 47222044)
3. Wark PA, Johnston SL, Moric I, Simpson JL, Hensley MJ, Gibson PG. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 2002;19:68-75. (Pubitemid 34105570)
4. Esther CR Jr, Alexis NE, Clas ML, Lazarowski ER, Donaldson SH, Ribeiro CM, Moore CG, Davis SD, Boucher RC. Extracellular purines are biomarkers of neutrophilic airway inflammation. Eur Respir J 2008;31:949-956.
5. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 1996;272:735-738.
6. Di Virgilio F. Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol Sci 2007;28:465-472.
7. Müller T, Paula Vieira R, Grimm M, Durk T, Cicko S, Zeiser R, Jakob T, Martin SF, Blumenthal B, Sorichter S, et al. A potential role for P2X7R in allergic airway inflammation in mice and humans. Am J Respir Cell Mol Biol 2011;44:456-464.
8. Denlinger LC, Shi L, Guadarrama A, Schell K, Green D, Morrin A, Hogan K, Sorkness RL, Busse WW, Gern JE. Attenuated P2X7 pore function as a risk factor for virus-induced loss of asthma control. Am J Respir Crit Care Med 2009;179:265-270.
9. Buell GN, Talabot F, Gos A, Lorenz J, Lai E, Morris MA, Antonarakis SE. Gene structure and chromosomal localization of the human P2X7 receptor. Receptors Channels 1998;5:347-354. (Pubitemid 28499715)
10. Barnes KC, Neely JD, Duffy DL, Freidhoff LR, Breazeale DR, Schou C, Naidu RP, Levett PN, Renault B, Kucherlapati R, et al. Linkage of asthma and total serum IgE concentration to markers on chromosome 12q: evidence from Afro-Caribbean and caucasian populations. Genomics 1996;37:41-50. (Pubitemid 26341832)
11. Dizier MH, Besse-Schmittler C, Guilloud-Bataille M, Annesi-Maesano I, Boussaha M, Bousquet J, Charpin D, Degioanni A, Gormand F, Grimfeld A, et al. Genome screen for asthma and related phenotypes in the French EGEA study. Am J Respir Crit Care Med 2000;162:1812-1818.
12. Xu J, Postma DS, Howard TD, Koppelman GH, Zheng SL, Stine OC, Bleecker ER, Meyers DA. Major genes regulating total serum immunoglobulin E levels in families with asthma. Am J Hum Genet 2000;67:1163-1173.
13. Raby BA, Silverman EK, Lazarus R, Lange C, Kwiatkowski DJ, Weiss ST. Chromosome 12q harbors multiple genetic loci related to asthma and asthma-related phenotypes. Hum Mol Genet 2003;12:1973-1979. (Pubitemid 37038806)
14. Shao C, Suzuki Y, Kamada F, Kanno K, Tamari M, Hasegawa K, Aoki Y, Kure S, Yang X, Endo H, et al. Linkage and association of childhood asthma with the chromosome 12 genes. J Hum Genet 2004;49:115-122. (Pubitemid 38506724)
15. Brasch-Andersen C, Tan Q, Borglum AD, Haagerup A, Larsen TR, Vestbo J, Kruse TA. Significant linkage to chromosome 12q24.32-q24.33 and identification of sfrs8 as a possible asthma susceptibility gene. Thorax 2006;61:874-879. (Pubitemid 44570308)
16. Celedon JC, Soto-Quiros ME, Avila L, Lake SL, Liang C, Fournier E, Spesny M, Hersh CP, Sylvia JS, Hudson TJ, et al. Significant linkage to airway responsiveness on chromosome 12q24 in families of children with asthma in Costa Rica. Hum Genet 2007;120:691-699. (Pubitemid 44942853)
17. Fuller SJ, Stokes L, Skarratt KK, Gu BJ, Wiley JS. Genetics of the P2X7 receptor and human disease. Purinergic Signal 2009;5:257-262.
18. Gu BJ, Zhang W, Worthington RA, Sluyter R, Dao-Ung P, Petrou S, Barden JA, Wiley JS. A glu-496 to ALA polymorphism leads to loss of function of the human P2X7 receptor. J Biol Chem 2001;276:11135-11142. (Pubitemid 38089296)
19. Wiley JS, Dao-Ung LP, Li C, Shemon AN, Gu BJ, Smart ML, Fuller SJ, Barden JA, Petrou S, Sluyter R. An ile-568 to as polymorphism prevents normal trafficking and function of the human P2X7 receptor. J Biol Chem 2003;278:17108-17113. (Pubitemid 36799588)
20. Gu BJ, Sluyter R, Skarratt KK, Shemon AN, Dao-Ung LP, Fuller SJ, Barden JA, Clarke AL, Petrou S, Wiley JS. An arg307 to glen polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor. J Biol Chem 2004;279:31287-31295. (Pubitemid 39037794)
21. Shemon AN, Sluyter R, Fernando SL, Clarke AL, Dao-Ung LP, Skarratt KK, Saunders BM, Tan KS, Gu BJ, Fuller SJ, et al. A thr357 to ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages. J Biol Chem 2006;281:2079-2086. (Pubitemid 43845796)
22. Roger S, Mei ZZ, Baldwin JM, Dong L, Bradley H, Baldwin SA, Surprenant A, Jiang LH. Single nucleotide polymorphisms that were identified in affective mood disorders affect ATP-activated P2X7 receptor functions. J Psychiatr Res 2010;44:347-355.
23. Denlinger LC, Coursin DB, Schell K, Angelini G, Green DN, Guadarrama AG, Halsey J, Prabhu U, Hogan KJ, Bertics PJ. Human P2X7 pore function predicts allele linkage disequilibrium. Clin Chem 2006;52:995-1004. (Pubitemid 43794409)
24. Stokes L, Fuller SJ, Sluyter R, Skarratt KK, Gu BJ, Wiley JS. Two haplotypes of the P2X(7) receptor containing the ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1beta secretion. FASEB J 2010;24:2916-2927.
25. Denlinger LC, Angelini G, Schell K, Green DN, Guadarrama AG, Prabhu U, Coursin DB, Bertics PJ, Hogan K. Detection of human P2X7 nucleotide receptor polymorphisms by a novel monocyte pore assay predictive of alterations in lipopolysaccharide-induced cytokine production. J Immunol 2005;174:4424-4431. (Pubitemid 40396026)
26. Korpi-Steiner NL, Sheerar D, Puffer EB, Urben C, Boyd J, Guadarrama A, Schell K, Denlinger LC. Standardized method to minimize variability in a functional P2X(7) flow cytometric assay for a multi-center clinical trial. Cytometry B Clin Cytom 2008;74:319-329.
27. Shi L, Manthei DM, Guadarrama AG, Lenertz LY, Denlinger LC. Rhinovirus-induced IL-1beta release from bronchial epithelial cells is independent of functional P2X7. Am J Respir Cell Mol Biol 2012;47:363-371.
28. Denlinger LC, Sorkness CA, Chinchilli VM, Lemanske RF Jr. Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network. J Allergy Clin Immunol 2007;119:3-11. (Pubitemid 46043384)
29. Sutherland ER, King TS, Icitovic N, Ameredes BT, Bleecker E, Boushey HA, Calhoun WJ, Castro M, Cherniack RM, Chinchilli VM, et al. A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol 2010;126:747-753.
30. Calhoun WJ, Ameredes BT, King TS, Icitovic N, Bleecker E, Castro M, Cherniack RM, Chinchilli VM, Craig TJ, Denlinger L, et al. Comparison of inhaled corticosteroid adjustment strategies for long term asthma management: the ACRN BASALT trial. JAMA 2012;308:987-997.
31. Manthei DM, Jackson DJ, Evans MD, Gangnon RE, Tisler CJ, Gern JE, Lemanske RF Jr, Denlinger LC. Protection from asthma in a high-risk birth cohort by attenuated P2X7 function. J Allergy Clin Immunol 2012;130:496-502.
32. Michel AD, Chambers LJ, Clay WC, Condreay JP, Walter DS, Chessell IP. Direct labelling of the human P2X7 receptor and identification of positive and negative cooperativity of binding. Br J Pharmacol 2007;151:103-114.
33. Yan Z, Khadra A, Li S, Tomic M, Sherman A, Stojilkovic SS. Experimental characterization and mathematical modeling of P2X7 receptor channel gating. J Neurosci 2010;30:14213-14224.
34. Li Q, Zhang H, Yu K. Approaches for evaluating rare polymorphisms in genetic association studies. Hum Hered 2010;69:219-228.
35. Perregaux DG, Gabel CA. Post-translational processing of murine IL-1: evidence that ATP-induced release of IL-1 alpha and IL-1 beta occurs via a similar mechanism. J Immunol 1998;160:2469-2477. (Pubitemid 28119933)
36. McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CC, Beck PL, Muruve DA, Kubes P. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 2010;330:362-366.
37. Welter-Stahl L, da Silva CM, Schachter J, Persechini PM, Souza HS, Ojcius DM, Coutinho-Silva R. Expression of purinergic receptors and modulation of P2X7 function by the inflammatory cytokine IFNgamma in human epithelial cells. Biochim Biophys Acta 2009;1788:1176-1187.
38. Gorodeski GI. P2X7-mediated chemoprevention of epithelial cancers. Expert Opin Ther Targets 2009;13:1313-1332.
39. Gu BJ, Saunders BM, Jursik C, Wiley JS. The P2X7-nonmuscle myosin membrane complex regulates phagocytosis of nonopsonized particles and bacteria by a pathway attenuated by extracellular ATP. Blood 2010;115:1621-1631.
40. Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, Holgate ST, Davies DE. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005;201:937-947. (Pubitemid 40524463)
41. Tesfaigzi Y. Roles of apoptosis in airway epithelia. Am J Respir Cell Mol Biol 2006;34:537-547.
42. Huynh ML, Malcolm KC, Kotaru C, Tilstra JA, Westcott JY, Fadok VA, Wenzel SE. Defective apoptotic cell phagocytosis attenuates prostaglandin E2 and 15-hydroxyeicosatetraenoic acid in severe asthma alveolar macrophages. Am J Respir Crit Care Med 2005;172:972-979. (Pubitemid 41476533)
43. Fitzpatrick AM, Holguin F, Teague WG, Brown LA. Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma. J Allergy Clin Immunol 2008;121:1372-1378.